MRIGlobal works with animal vaccine company on human Covid-19 vaccine
MBF Therapeutics, which to date has focused on developing DNA-based vaccines for animals, said Thursday it has formed a collaboration with four life science industry partners to work on a Covid-19 vaccine for humans.
The collaboration with MRIGlobal, Rymedi, SSI Strategy and Aldevron will seek to advance MBF Therapeutics’ SARS CoV-2 vaccine candidate COVE-001. Financial terms of the partnership are being kept confidential.
“Our goal is a better long-term solution to the current global pandemic,"…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: John George Source Type: news
More News: Biotechnology | COVID-19 | Health Management | Pandemics | Partnerships | SARS | Science | Vaccines | Veterinary Vaccinations